INTRODUCTION
Virus cell entry requires the interaction of the viral envelope proteins with a specific cellular receptor(s), which determines the specificity of a virus for a particular host. Transferrin receptor 1 (TfR1), the cell-surface receptor for iron-loaded transferrin required for iron uptake into cells (Aisen, 2004) , is known to serve as the primary cellular receptor for viruses belonging to three unrelated families: Parvoviridae (canine and feline parvoviruses), Arenaviridae (several rodent and human arenaviruses) and Retroviridae [the betaretrovirus mouse mammary tumour virus (MMTV)] (Abraham et al., 2009; Flanagan et al., 2008; Parker et al., 2001; Radoshitzky et al., 2008; Ross et al., 2002) .
Canine parvovirus represents an important model for disease emergence in the wild. This virus emerged in dogs in the late 1970s when it was passed to dogs as a host-range variant of a feline parvovirus. Interestingly, it now appears that the transmission from cats to dogs and the subsequent emergence of the canine parvovirus was an indirect event involving passage through another carnivore species, racoon . The cross-species transmission was accompanied by the acquisition of only a few mutations that allowed efficient binding of the virus not only to the feline but also to the canine TfR1 orthologue (Hueffer et al., 2003) .
New World clade B arenaviruses typically circulate in rodent species found in South America. Several of these viruses (e.g. Machupo virus, Junin virus, Guanarito virus and Sabia virus) are, however, emerging in human populations, where they cause haemorrhagic fever and lethal disease (Charrel & de Lamballerie, 2003; Choe et al., 2011) . The ability to use the human TfR1 (hTfR1) in addition to their native rodent TfR1 correlates with their zoonotic potential (Choe et al., 2011) . Whereas clade B arenaviruses that do not cause human disease (e.g. Amapari virus and Tacaribe virus) cannot utilize hTfR1 for cell entry, the IP: 54.70.40.11
On: Thu, 06 Dec 2018 04:10:27 pathogenic clade B arenaviruses effectively recognize the human orthologue, leading to more efficient infection of human cells and, in turn, zoonotic transmission (Abraham et al., 2009; Flanagan et al., 2008; Radoshitzky et al., 2008) . Studies have shown that changes in as little as 1 aa of hTfR1 were sufficient for non-pathogenic arenaviruses to gain use of the receptor for cell entry (Abraham et al., 2009) . Similarly, mutation of only a few amino acid residues enabled the conversion of the mouse TfR1 (mTfR1) to a compatible cell-entry receptor for pathogenic arenaviruses (Radoshitzky et al., 2008) . At present, there is limited information about the determinants of receptor binding within the arenavirus entry glycoprotein, GP1. However, based on the aforementioned studies, it can be inferred that only minor changes in the receptor-binding domain of GP1 may dramatically change arenavirus tropism.
Thus, in both canine parvoviruses and New World clade B arenaviruses, the major cellular barrier preventing crossspecies transmission and zoonosis appears to be the incompatibility of TfR1 with the viral TfR1-binding domain. The barrier is, however, rather weak, with only a small number of point mutations in either the viral TfR1-binding domain or TfR1 itself allowing expansion of virus host range. Indeed, reconstruction of TfR1 evolution has provided strong evidence for repeated cross-species transmission of parvoviruses and arenaviruses and an ongoing host-virus arms race shaping their genomes (Demogines et al., 2013; Kaelber et al., 2012) .
MMTV, the prototypic betaretrovirus causing mouse mammary epithelial cell tumours, also utilizes its host species TfR1 for cell entry (Ross et al., 2002) . In the wild, the virus specifically infects rodents of the species Mus musculus. However, it appears that MMTV-like viruses once circulated more widely among rodents and other mammalian species. This belief is based on the presence of remnants of ancient infections, endogenous betaretroviral sequences, in the genomes of several mammalian species including rodents, bats, primates, ruminants and marsupials (Demogines et al., 2013; Hayward et al., 2013) . More common occurrences of MMTV-like viruses can also be inferred from the recent observation that the amino acid residues corresponding to the MMTV envelope protein (Env)-binding site of mTfR1 were subjected to positive selection pressure (Demogines et al., 2013) . This indicates that rodent species, currently devoid of infectious MMTV, have, during evolution, adapted (through the acquisition of mutations within TfR1) to block MMTV-like virus entry. Collectively, these findings suggest that betaretroviruses may be particularly adept at evading host defences and that the cross-species transmission of betaretroviruses has commonly occurred.
There have been conflicting reports regarding the ability of MMTV to infect human cells. Historically, this may stem from difficulties in working with the prototypic betaretrovirus due to the low infectivity observed for MMTV in cell culture, as well as the cumbersome construction of a functional molecular clone for the production of recombinant virus. Nevertheless, WT virus (i.e. harvested from tissue-culture fluids of MMTV-induced mouse mammary carcinoma cell lines or milk collected from nursing mice) originating from GR and RIII mice has been shown to productively infect, in addition to murine cells, various heterologous cell lines including those of human origin, albeit less efficiently than mouse cells (Crandell et al., 1973; Howard et al., 1977; Hsu et al., 2010; Indik et al., 2005a; Indik et al., 2007; Lasfargues et al., 1979) . Importantly, the infectivity of both WT and egfp-marked virus was neutralized by specific anti-MMTV antiserum (Indik et al., 2005a; Indik et al., 2007) . The infectivity of the egfp-marked MMTV virus was also abolished when Env was mutated, providing evidence for specific Env-mediated transfer of MMTV to the target cells (Indik et al., 2005a) . Furthermore, the initially established infection of human Hs578T cells with WT MMTV(GR) virus was sufficient for virus spread, ultimately leading to the infection of every cell in culture (Indik et al., 2007) .
In contrast to MMTV(GR) and MMTV(RIII), WT MMTV from C3H mice [MMTV(C3H)], has been reported to be incapable of infecting human cells, despite its relatively efficient binding to hTfR1 (Ross et al., 2002; Wang et al., 2008) . Virus entry was reported to be blocked at the postattachment phase, due to lack of internalization of MMTVbound hTfR1 and subsequent trafficking to the late endosome, where membrane fusion occurs . Thus, it is reasonable to hypothesize that MMTV(C3H) may represent a host-range variant incapable of entering non-murine cells. Alternatively, the observed discrepancy between the various MMTV strains may be due to differences in the sensitivity of techniques used to detect virus infection. Most of the studies with MMTV(C3H) were performed using a surrogate infection/ transduction system based on murine leukemia virus (MLV) cores pseudotyped with MMTV Env, which, in our hands, exhibits compromised infectivity compared with the WT MMTV(GR). It is thus conceivable that a lower efficiency of the MLV[MMTV Env] pseudoparticles was sufficient to establish infection of murine cells but was not sufficient for infection of the less-sensitive human cells.
Here, we used our novel, highly sensitive MMTV-based vector production system (Konstantoulas & Indik, 2014) for transduction of cells of various origins, to determine whether MMTV(C3H) could infect heterologous cells. Additionally, we analysed whether MMTV(C3H) was capable of productively infecting human cells, and finally we directly compared the infectivity of MMTV(C3H) with that of MMTV(GR).
RESULTS
Infection/transduction of human cells with WT MMTV(C3H) and egfp-containing MMTV-based vectors carrying MMTV(C3H)Env
To investigate whether MMTV(C3H) infects non-murine cells, single-round transduction experiments were carried out initially using MMTV-based vector particles carrying MMTV Env (GR or C3H), ecotropic MLV Env or amphotropic 4070A MLV Env (generated using our recently described novel high-titre MMTV-based vector production system (Konstantoulas & Indik, 2014) ). Prior to transduction, virus particle titres were determined by real-time TaqMan reverse transcriptase (RT)-PCR targeting the egfp gene and normalized virus levels were used for the transduction of human (Hs578T) and murine (NMuMG) mammary epithelial cells.
As expected, the human cells were transduced with MMTV recombinant particles pseudotyped with the MLV 4070A Env (Fig. 1d) but not with the particles carrying the Env derived from the ecotropic MLV (Fig. 1e) , which, however, successfully transduced cultured murine cells (Fig. 1a) . In agreement with previously published data, Hs578T cells were susceptible to transduction with MMTV cores carrying the MMTV(GR) Env (MMTV[GR Env]) (Fig. 1b) . Importantly, MMTV cores carrying the MMTV(C3H)Env (MMTV[C3H Env]) also successfully transduced Hs578T cells (Fig. 1c) , the sensitivity being Hs578T cells to MMTV[GR Env] and MMTV[C3H Env] particles was only approximately two-to threefold lower than the sensitivity exhibited by NMuMG cells (Fig. 1a-c) .
The transduction efficiency of the MMTV[C3H Env] particles on Hs578T cells was slightly reduced (~30 % reduction) compared with the efficiency obtained with MMTV[GR Env] particles (Fig. 1b, c) . The infectivity of both MMTV[C3H Env] and MMTV[GR Env] particles was completely blocked after pre-incubation with neutralizing goat anti-MMTV antibodies (Fig. 1b, c) . In contrast, pretreatment of the virions with non-specific serum had no effect on the infectivity (Fig. 1b, c) . Importantly, no alteration in the infectivity was observed when the MLV 4070A Env-carrying pseudovirions were pre-incubated with the anti-MMTV antibodies (Fig. 1d) , ruling out non-specific infection inhibition activity of the serum. Furthermore, the incubation of supernatants at 60 u C for 10 min, prior to transduction of human cells, eliminated the infectivity of vectors regardless of the Env used ( Fig. 1b-d) , showing that transmission of vector DNA was temperature sensitive, as expected for vector transduction rather than for other means of DNA transfer. Finally, the addition of an inhibitor of reverse transcriptase activity, 39-azido-29-deoxythymidine (AZT; 37 mM), to the culture medium of the transduced human cells inhibited transduction ( Fig. 1b-d) , further demonstrating that the presence of vector DNA in the transduced cells resulted from the reverse transcriptiondependent process, as expected for vector transduction.
To corroborate the results obtained using egfp-marked MMTV-based vectors carrying MMTV(C3H)Env, we used WT MMTV obtained from supernatants of an MMTVinduced mouse mammary tumour cell line derived from the C3H/HeN mouse strain (Mm5MT) (Owens & Hackett, 1972) . As a positive control, MMTV(GR), harvested from supernatants of cells derived from the GR mouse strain (Ringold et al., 1975) , was used for infection of human (HEK293, HeLa and Hs578T) and feline (CrFK) cells. All three human cell lines, as well as CrFK cells, which are known to be highly permissive for MMTV infection (Crandell et al., 1973) , became infected, as illustrated by the presence of an MMTV-specific PCR product [targeting the MMTV long terminal repeat (LTR)-gag region] (Fig.  2a, b) . No such PCR product was amplified from their uninfected counterparts even though the same amount of genomic (g)DNA was used for amplification ( Fig. 2a, b) .
Infection of human cells was completely blocked by preincubating WT virus, MMTV(C3H) or MMTV(GR), with neutralizing goat anti-MMTV antibodies, as illustrated by the absence of the indicative PCR product (Fig. 2c, d ). In contrast, pre-treatment of virus with non-specific serum had no effect on the infectivity of the WT viruses (Fig. 2c,  d ), confirming the specificity of the interaction between the virus and its cellular receptor. Heat inactivation of the virus eliminated the infection, as no PCR product was detected in Hs578T cells infected with heat-treated viruses (60 u C, 10 min) produced from either Mm5MT Taken together, the results obtained with WT MMTV(C3H) and MMTV-based vectors carrying MMTV(C3H)Env demonstrated that MMTV(C3H), like MMTV(GR), has the capability to establish infection of human cells and that the infection is mediated by MMTV Env. The observation that the infectivity of both the WT virus and the vector was blocked by heat treatment, an inhibitor of reverse transcription (AZT) and neutralizing anti-MMTV antibodies (which did not show a non-specific antiviral activity; the infectivity of vectors carrying heterologous Envs were not affected), together with the fact that virus harvested from supernatants of producer cells was filtered (0.45 mm) prior to infection, provide several lines of evidence supporting the concept of authentic infection rather than non-specific events, such as carry-over of proviral DNA from the producer cells, infection with virions pseudotyped with envelopes from other viruses, transfer of producer cells or nonspecific virus uptake. Moreover, the infected cells were unequivocally of human origin (Fig. S1 , available in the online Supplementary Material). Integration sites hosting MMTV(C3H) provirus, determined using a ligationmediated (LM)-PCR protocol optimized for the amplification of virus-host junction sequences (Indik et al., 2007) , were clearly identified as human sequences and could be unambiguously mapped (¢99.8 % nucleotide identity starting ¡1 nt from the proviral end) to loci in the human genome (Table 1) , providing further evidence of infection of human cells.
MMTV(C3H) productively infects human breast cells in culture
The ability of MMTV(C3H) to replicate in cultured human mammary cells (Hs578T) was addressed in subsequent time-course experiments. MMTV(GR) was used as a positive control (Indik et al., 2007) . Prior to infection, virus particle titres were determined by real-time TaqMan RT-PCR targeting the 59 end of env, and normalized virus levels were used for infection of human cells. Quantification of proviral DNA at 1 week post-infection (p.i.), using realtime TaqMan PCR, showed approximately equivalent proviral loads in the infected cells. Next, the cells were cultured in the presence or absence of dexamethasone (DEX; 10 26 M) and gDNA was extracted at regular time points. We reasoned that if human cells are able to support MMTV(C3H) replication, increasing levels of proviral DNA should be observed upon cultivation of these cells with DEX. As expected, increasing levels of proviral DNA were detected within Hs578T cells infected with MMTV(GR) over time (Fig. 3a, e) , as assessed by semi-quantitative (targeting the 
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MMTV ( MMTV LTR-gag region) and quantitative (targeting the 59 end of the env-encoding region) PCR. Importantly, an increase in proviral DNA levels was also detected for cells infected with MMTV(C3H) (Fig. 3c, f) . This increase was, however, observed only when cells were cultivated with DEX ( Fig. 3c-f ). Virus replication in human cells was further demonstrated by increased viral RNA (vRNA) levels at later cultivation time points in the culture supernatants of cells cultured in the DEX-containing medium (Fig. 3i, j) .
Interestingly, although similar levels of proviral DNA were detected at early cultivation time points in cells infected with the two viral strains, a delayed increase in proviral copy number was observed for MMTV(C3H) (Fig. 3a, b) . Based on the quantitative PCR data, it can be inferred that all Hs578T cells infected with MMTV(GR) carried at least one copy of the proviral DNA at 35 days p.i. (Fig. 3e) . In contrast, approximately 15 % of cells infected with MMTV(C3H) carried a copy of the proviral DNA at 45 days p.i. Moreover, MMTV(C3H)-infected Hs578T cells needed to be cultured for at least 80 days before all cells carried at least one copy of the proviral DNA (Fig. 3f ).
Hs578T cells infected with MMTV(C3H) or MMTV(GR)
were subsequently cultured in DEX-containing medium (10 26 M) in the presence or absence of AZT (37 mM), to determine whether the increased proviral DNA and vRNA levels were due to ongoing retrovirus replication, which depends on reverse transcription. Importantly, no noticeable increase in proviral DNA levels was detected in cells cultured in the AZT-supplemented medium (Fig. 4) . Thus, the elevated proviral copy numbers at later time points were due to ongoing replication of the betaretroviruses rather than a clonal expansion of initially infected cells.
To determine whether the infected cells expressed MMTV proteins and to quantify the infected cells by a non-PCRbased technique, indirect immunofluorescence staining with monospecific anti-MMTV-CA polyclonal serum was performed. A noticeable difference in the numbers of MMTV capsid (CA) protein-expressing cells was detected in the time-course experiment (Fig. 5) . Whereas only a small number of MMTV-positive cells were detected in Hs578T cells shortly (1 week) after infection with MMTV(GR) (Fig. 5b) , by week 6 the majority of cells expressed MMTV antigen (Fig. 5d) . For Hs578T cells infected with MMTV(C3H), again only a small number of MMTVpositive cells were observed shortly after infection (Fig. 5f) . In contrast to MMTV(GR)-infected Hs578T cells, and similar to what was observed with the quantitative PCR data, only a modest proportion of the MMTV(C3H)-infected cells expressed the MMTV antigen by week 6 (Fig.  5h) . The majority of MMTV(C3H)-infected Hs578T cells did, however, express the MMTV CA protein by week 14 (Fig. 5j) . The increase was strictly DEX dependent, as no increase in the number of CA-positive cells could be observed upon cultivation of cells in DEX-free medium (Fig. 5c, g, i) . These data demonstrated that the infected cells expressed viral structural proteins in a DEX-dependent manner and further support our quantitative PCR results showing that, at later cultivation times, all human cells became infected with MMTV(C3H).
Persistently infected human cells produce infectious MMTV(C3H) particles
To ascertain whether human cells persistently infected with MMTV(C3H) (15 weeks p.i.) or MMTV(GR) (6 weeks p.i.) produced infectious particles, the filtered supernatants obtained from these cells, after stimulation with DEX, were applied onto naïve HEK293, Hs578T, HeLa and CrFK cells. The DNA from these cells was subjected to the MMTVspecific PCR analysis at 1 week p.i. A PCR product of the expected size (717 bp) was obtained from the DNA of cells infected with either MMTV(C3H) (Fig. 6b) or MMTV(GR) (Fig. 6a) but not from that of mock-infected cells. This result indicated that infected human cells released virions that were capable of infecting cells in culture. We designated these viruses MMTV(C3H)hp1 and MMTV(GR)hp1. Comparison of 10 complete MMTV(C3H)hp1 and MMTV(GR)hp1 proviral sequences (minus the gag gene, which contains a poison sequence; Brookes et al., 1986) with MMTV(C3H) and MMTV(GR) sequences identified in virus preparations from murine mammary carcinoma cells, respectively, revealed that MMTV(C3H)hp1 and MMTV(GR)hp1 did not contain sequences from other viruses, the mouse genome [including endogenous mouse mammary tumour proviruses (Mtvs)] or the human genome ( Fig. S2 and data not shown).
Several experiments were subsequently conducted to characterize the MMTV(C3H)hp1 and MMTV(GR)hp1 particles produced from the persistently infected human cells. Importantly, infection of human cells was completely blocked by pre-incubating MMTV(C3H)hp1 or MMTV(GR)hp1 virus with the neutralizing goat anti-MMTV antibodies, as no MMTV-specific signal could be detected in PCR analysis of cells exposed to virus-anti-MMTV serum mixtures (Fig. 6c, d ). Furthermore, no PCR signal could be detected when MMTV(GR)hp1 and MMTV(C3H)hp1 were incubated at 60 u C for 10 min prior to infection or when AZT was added to the cellculture medium of naive Hs578T cells at the time of infection (Fig. 6c, d ). Collectively, these results demonstrated that MMTV(C3H)hp1 and MMTV(GR)hp1 are antigenically related to the virus produced from murine cells, and showed that the presence of MMTV(C3H)hp1 and MMTV(GR)hp1 proviral DNA in infected cells, was due to an authentic, receptor-mediated and reverse transcriptase-dependent infection process.
DISCUSSION
The data presented here demonstrate that MMTV(C3H) is not a host-range variant of MMTV incapable of infecting human cells. Using both WT MMTV(C3H) and MMTVbased vectors carrying MMTV(C3H)Env, we established infection of human mammary epithelial cells, Hs578T, previously shown to be susceptible to infection with MMTV(GR) (Indik et al., 2005a; Indik et al., 2007) . In addition to establishing infection of human cells, MMTV(C3H) was, like MMTV(GR), also able to replicate in human Hs578T cells. Of note, differences in the kinetics of productive infection between MMTV(C3H) and MMTV(GR) were observed. Whereas de novo MMTV(GR) was detected in supernatant fluids as soon as 14 days p.i., the appearance of de novo MMTV(C3H) was delayed to 35 days p.i. The delayed replication kinetics of MMTV(C3H) cannot be explained by a lower m.o.i. for MMTV(C3H), as RNA viral loads and infectious titres were determined in a single-round infection experiment (using quantitative PCR to quantify proviral DNA loads) prior to the time-course experiments. However, the quantitative PCR employed cannot distinguish between exogenous and endogenous MMTV sequences that may also be packaged into virions. Thus, it is conceivable that endogenous Mtv-1, Mtv-6, Mtv-8, Mtv-11 and Mtv-14 RNAs, which have been reported to be expressed in mammary glands of C3H/HeN mice (Kozak et al., 1987) , may be co-packaged with the exogenous MMTV(C3H) RNA. Recombination occurring during reverse transcription may result in the formation of a crippled recombinant virus incapable of replication. Sequencing of several MMTV(C3H) proviruses did not reveal the presence of such recombinants in infected cells. Alternatively, the observed differences in replication kinetics may be due to the genetic make-up of the two betaretrovirus strains. Of note, differences in the occurrence of MMTV-induced tumours have been described previously for these two viral strains. In GR mice, MMTV infection leads to mammary tumour formation with a high incidence (.90 %) and at an early age (Bentvelzen et al., 1970) . In contrast, mammary tumours induced in MMTVinfected C3H/HeN mice have a longer latency period and a moderate incidence (Golovkina et al., 1993) . Obviously, although other factors such as the host genetic background, in addition to the genetic make-up of the MMTVs, account for the differences in the in vivo infection progression and incidence of mammary tumours, the faster replication kinetics may also be, in part, an intrinsic property of the exogenous betaretrovirus present in the GR mice (Held et al., 1993; Hook et al., 2000; Janeway, 1991; Marrack et al., 1991) .
MMTV, like parvoviruses and New World clade B arenaviruses, uses the TfR1 orthologue of its host species to mediate cell entry (Abraham et al., 2009; Flanagan et al., 2008; Parker et al., 2001; Radoshitzky et al., 2008; Ross et al., 2002) . Both canine parvoviruses and New World clade B arenaviruses can easily adapt to use the TfR1 of new species, resulting in the cross-species transmission of these two unrelated virus families (Charrel & de Lamballerie, 2003; Choe et al., 2011; Hueffer et al., 2003) . In the case of MMTV, previous studies suggest that MMTV is incapable of utilizing the TfR1 of other species to establish infection ( Wang et al., 2006) . The presence of endogenous betaretroviral sequences in mammalian hosts of wide geographical and evolutionary diversity (Demogines et al., 2013; Hayward et al., 2013) , and the observation that the parts of the rodent TfR1 that interact with the MMTV Env are under positive selection pressure (Demogines et al., 2013) , however, suggests that cross-species transmission of betaratroviruses has commonly occurred. It is thus plausible that MMTV may adapt to use TfR1 from nonmurine species or may use other receptors or co-receptors to establish infection of heterologous cells. The concept of an alternative receptor is further supported by the observation that feline TfR1, derived from the most susceptible cell line, CrFK, does not make cells susceptible to MMTV infection (Wang et al., 2006) . Therefore, feline cells must express another molecule, different from TfR1, that enables the virus to enter the cytoplasm very efficiently. Work to determine whether hTfR1 plays a role in MMTV-mediated infection of human cells is currently ongoing. Of note, non-pathogenic New World arenavirus strains are able to enter human and rat cells relatively efficiently, despite their inability to bind human or rat TfR1, suggesting that non-pathogenic and possibly other clade B arenaviruses may also use more than one receptor for cell entry (Abraham et al., 2009; Flanagan et al., 2008 ). An alternative receptor may substitute for hTfR1; alternatively, it may function downstream of TfR1 in manner analogous to the human immunodeficiency virus type 1 co-receptors, CCR5 and CXCR4.
There have been reports that continued passage of MMTV in human mammary carcinoma cell lines (BT474 and were cultured for 7 weeks in medium containing 10 "6 M DEX supplemented with AZT (37 mM) or not. gDNA was extracted from infected cells at the indicated time points and semiquantitative PCR performed. ", Non-transduced Hs578T cells; +, producer cells. Equal DNA loading was controlled using GAPDH-specific primers (bottom panels). (e-h) Real-time TaqMan PCR was performed for an accurate quantification of proviral loads in Hs578T cells infected with MMTV(GR) (e) or MMTV(C3H) (f). Equal loading of the PCRs were quantified in a real-time TaqMan PCR specific for the APOB gene (g, h). 
MMTV(C3H) infects human mammary epithelial cells
MCF-7) results in an adapted virus that can infect human cells (Howard & Schlom, 1978; Lasfargues et al., 1979) . Similarly, the serial passage of arenaviruses in cell lines or animals results in virus adaptation that gives the virus the capacity to infect cells, animals and tissues of different origins (reviewed by Zapata & Salvato, 2013) . Finally, the passage of feline panleukopenia virus in racoons resulted in adapted virus that was capable of infecting dogs, in addition to cats, ultimately leading to the emergence of canine parvovirus type 2a . It would thus be interesting to see if the continued passage of MMTV(C3H) in human Hs578T cells allows the virus to adapt through, for example, alterations in the viral glycoprotein that optimize the interaction with its cellular receptor(s) (TfR1 or otherwise), allowing more efficient infection of human cells.
In conclusion, we have consolidated and expanded our previous findings by showing that MMTV(C3H), like MMTV(GR), has the potential to infect and replicate in cultured human breast cells. This observation, together with the presence of endogenous betaretroviral sequences in mammalian genomes and the finding that the parts of the rodent TfR1 that interact with the MMTV Env are under positive selection pressure, suggests that crossspecies transmission of betaratroviruses may be possible.
METHODS
Cell culture. CrFK, HeLa, Hek293T, Hs578T, CHO, GR and Mm5MT (ATCC CRL-1637) cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10 % FBS. All cultured cells were maintained at 37 uC in humidified air containing 5 % CO 2 .
Plasmid construction. The construction of the packaging construct (pCMgpRRE17), the EGFP-labelled MMTV vector plasmid (pRRpCeGFPWPRE25) and the Rev expression construct (pLP2) has been outlined previously (Konstantoulas & Indik, 2014) . Likewise, the ecotropic MLVEnv-encoding plasmid (pHCMV-EcoEnv; Addgene 15802) (Sena-Esteves et al., 2004) , the amphotropic MLVEnv-encoding plasmid (pAlf) (Cosset et al., 1995) and the MMTV(GR)Env-encoding plasmid [pEnv(GR)] (Indik et al., 2005b; Müllner et al., 2008) have all been described previously. pEnv(GR) shows 99.85 % nucleotide identity to WT MMTV(GR)env sequences identified in virus preparations from GR (an MMTV-induced murine mammary adenocarcinoma cell line derived from the GR mouse strain; Ringold et al., 1975) cell-culture fluids (Fig. S3) . The MMTV(C3H)Env-encoding plasmid [pEnv(C3H)] was generated by high-fidelity PCR amplification of the complete env-encoding segment with primers 6684_F 6C, 30 min) with either anti-MMTV neutralizing antibody or non-specific serum (diluted 1 : 500). For heat inactivation, virus was incubated at 60 6C for 10 min. Where indicated, AZT (37 mM) was added to the culture medium of infected Hs578T cells. -ve, Non-transduced Hs578T cells; +ve, producer cells. Equal DNA loading was controlled in the PCR assay using GAPDH-specific primers (bottom panels). The experiments were performed three times with similar results; a representative experiment is shown.
